borderline significanceP = .05
Additionally, serum cortisol levels were reduced 3 months after tofogliflozin treatment, demonstrating borderline significance ( P = .05).
Additionally, serum cortisol levels were reduced 3 months after tofogliflozin treatment, demonstrating borderline significance ( P = .05).